TroVax Renal Immunotherapy Survival Trial

Clinical trial NCT00397345 · COMPLETED

Trial details

NCT number: NCT00397345
Sponsor: Oxford BioMedica
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Clear Cell Renal Carcinoma

Start date: 2006-09-01
Primary completion: 2009-12-01
Enrollment: 733

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.